Bristol-Myers Squibb Company
CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS
Last updated:
Abstract:
The present invention provides compounds of Formula (I): ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
Status:
Application
Type:
Utility
Filling date:
12 Apr 2022
Issue date:
11 Aug 2022